Jan 15, 2024 · Lung disease is a serious potential health condition that can develop in people with systemic sclerosis (scleroderma). Interstitial lung disease occurs in most, but not all people …

The key elements of scleroderma lung disease involve 1) inflammation (potentially treatable); 2) lung scarring (not reversible but potentially preventable); and 3) blood vessel injury (treatable – …

Mar 26, 2024 · Pulmonary manifestations of scleroderma are demonstrated histologically in 90% of patients with scleroderma. It is a leading cause of mortality and at autopsy the lung is …

Jun 15, 2024 · When scleroderma affects the heart or lungs, it can cause shortness of breath, decreased exercise tolerance and dizziness. Scleroderma can cause scarring in the lung …

Two major pulmonary syndromes are associated with scleroderma; a pulmonary vascular disorder evolving over time into relatively isolated pulmonary arterial hypertension (PAH), and …

Feb 18, 2020 · Every patient with scleroderma should be looked at with a lung function test and high-resolution CT scan (HRCT). HRCT is likely to be more sensitive than a lung function test. …

Interstitial lung disease (ILD) occurs when there is scarring within the lungs and is the most common form of lung involvement in systemic sclerosis. In ILD, the walls of the small air sacs …

Scleroderma-related ILD, or scleroderma-associated Interstitial Lung Disease (SSc-ILD), occurs when there is inflammation and scarring to the lung tissue that supports the alveoli—the air …

Scleroderma-associated interstitial lung disease, or “SSc-ILD”, is a chronic lung disease in which scar tissue (“fibrosis”) and/or inflammation builds up in the walls of the air sacs of the lungs in …

If you have scleroderma, you may experience lung symptoms such as shortness of breath, cough, chest pain and dizziness. Learn when you consult your doctor.